DYADIC INTERNATIONAL INC Cash and Cash Equivalents
DYADIC INTERNATIONAL INC (DYAI) had Cash and Cash Equivalents of $1.43 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.43M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.25M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $4.62M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $5.83M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $1.43M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.25M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.62M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.83M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.14M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $5.06M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $6.51M 10-K · filed 2026-03-25 |
| 2024-09-30 | $5.92M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $6.13M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $10.57M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.52M 10-K · filed 2025-03-26 |
| 2023-09-30 | $7.40M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.84M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.37M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.79M 10-K · filed 2024-03-28 |
| 2022-09-30 | $6.74M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $9.48M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $12.42B 10-Q · filed 2022-05-12 |
| 2021-12-31 | $15.75M 10-K · filed 2023-03-29 |
| 2021-09-30 | $13.66M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $14.02M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $13.06M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $20.64M 10-K · filed 2022-03-29 |
| 2020-09-30 | $21.86M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $11.78M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $4.70M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.82M 10-K · filed 2021-03-30 |
| 2019-09-30 | $4.66M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $4.78M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $3.98M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.39M 10-K · filed 2020-03-30 |
| 2017-12-31 | $5.79M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |